Another study, which reported a high incidence of thyroid disorders (21%) with a PD-L1 inhibitor, concluded that elevated thyroid peroxidase (TPO) antibodies at the time of thyroid irAEs might impact the gravity of thyroid dysfunction, thus helping to identify patients who will progress to overt hypothyroidism and require thyroid hormone replacement [45]. Here, TPO is linked to hypothyroidism.